Senior Director, Cell Therapy Partnerships & Strategy – Neurology

Introduction to Role As Senior Director, Cell Therapy Partnerships & Strategy – Neurology, you will shape and execute AstraZeneca’s global Cell Therapy Strategic Site Partnership strategy, with Neurology as a primary focus. Working at the intersection of clinical development, clinical trial execution, and commercial readiness, you will help establish a differentiated AstraZeneca presence across the cell therapy and neurology ecosystem. You will lead strategic relationships with Key External Experts (KEEs), including leading neurology and cell therapy investigators, and priority clinical sites across our global portfolio. By developing a high-performing network of strategic partners, you will expand site and patient access, strengthen clinical trial delivery, and create long-term value that supports future commercial success. Why This Role This is an opportunity to define how AstraZeneca collaborates with leading neurology experts, investigators, treatment centers, and healthcare systems to advance cell therapy clinical development. You will bring deep scientific and clinical trial expertise to site strategy, helping partners overcome infrastructure, capacity, referral, and operational barriers that can limit delivery of complex therapies. Your work will support the development of scalable cell therapy networks across academic and community settings, strengthen AstraZeneca’s position as a preferred partner, and help prepare sites for the transition from clinical development to commercial delivery. Accountabilities Strategic Cell Therapy Partnership Development and Management • Own the disease-area site partnership strategy across the cell therapy portfolio, with Neurology as a strategic priority. • Identify, establish, and manage strategic partnerships with high-impact clinical sites globally to support AstraZeneca’s cell therapy portfolio across Neurology and other priority indications. • Lead strategic site partnership governance and engagement for assigned strategic sites. • Serve as the primary relationship owner for select strategic partners, supporting alignment, issue resolution, and joint value creation. • Cultivate trusted relationships with Key Opinion Leaders (KOLs), Key External Experts, investigators, clinical and administrative site leaders, and relevant external vendors. • Build strong partnerships with leading neurology and cell therapy investigators and institutions. • Represent AstraZeneca at industry meetings and scientific congresses, including ASH, EHA, AAN, ECTRIMS, and other relevant cell therapy and neurology forums. • Strengthen AstraZeneca’s visibility and reputation as a collaborative, neurology-focused cell therapy partner. • Exercise strategic ownership and cross-functional influence across complex initiatives that require senior-level judgment and coordination. Global Cell Therapy Site Strategy • Shape, own, and execute AstraZeneca’s global cell therapy site network strategy, with Neurology at the forefront alongside Hematology, Oncology, Biopharma, Rare Disease, and emerging therapeutic areas. • Identify and engage clinical sites that are critical to clinical trial participation, operational delivery, and scalable patient access. • Develop solutions that expand access to cell therapy, including delivery through community-based settings where appropriate. • Apply deep clinical and clinical trial expertise to address Neurology-specific site, patient, and treatment-delivery requirements. • Collaborate across Site Management, Clinical Operations, External Alliances, Medical Affairs, Commercial, Clinical Development, Manufacturing, and other functions to align and coordinate site strategies. • Engage with sites to understand and address barriers to cell therapy delivery at scale, including infrastructure, workforce, capacity, referral pathways, and operational challenges. • Strengthen the value proposition of becoming an AstraZeneca strategic partner through tailored site engagement strategies, master agreements, shared investment opportunities, and mutually beneficial initiatives. • Assess and improve site performance through targeted training, investment, and data-driven improvements in speed, quality, enrollment, and patient access. • Serve as the strategic owner accountable for site-strategy outcomes across the cell therapy Neurology portfolio. • Escalate and resolve issues that require executive-level judgment, cross-functional alignment, or enterprise-wide action. Site Segmentation, Archetyping, and Network Development • Lead site profiling, segmentation, and archetyping to identify the institutions best positioned to support cell therapy clinical development and future delivery in Neurology. • Characterize referral networks, patient pathways, site capabilities, and care settings to inform strategic priorities. • Evaluate site readiness for clinical trial execution and scalable delivery to patients. • Use site intelligence and portfolio priorities to simplify the network and focus resources where they can have the greatest impact. • Support the development of high-performing site networks across academic medical centers, specialty treatment centers, and community-based settings. • Identify opportunities to expand patient access beyond traditional academic centers while maintaining quality, safety, and regulatory requirements. Neurology Launch and Commercial Readiness • Support Commercial colleagues in defining and preparing the AZD0120 launch footprint for Neurology indications, with particular emphasis on the U.S. market. • Help expand patient access beyond traditional academic centers by identifying potential delivery models and strategic site opportunities. • Identify and address barriers to the delivery and adoption of CAR-T and other cell therapies. • Partner across Commercial, Medical, Clinical Development, Clinical Operations, Manufacturing, and other functions to support the transition of sites from clinical trials to commercial readin